
- Volume 0 0
AMNEAL AND INDOCO PARTNER TO MAKE GENERIC OPHTHALMICS
A new generic-industryjoint venturelinking New Jersey?based Amneal Pharmaceuticalsand India?sIndoco Remedieswill result in themarketing of at least10 generic ophthalmic products in the United States.
Amneal?s role in the partnership will be to prepare andfile abbreviated new drug applications for FDA approvaland to exclusively market these products throughout theUS pharmaceutical market. Indoco will be responsible formanufacturing the generics. Spokesmen for the 2 companiessaid that Indoco and Amneal have already begun toidentify several more ophthalmic products to pursue, aswell as other therapeutic categories and dosage forms.
Articles in this issue
about 18 years ago
Understanding Cholesterol: Do You Know Your Numbers?about 18 years ago
Case Studiesabout 18 years ago
can you READ these Rxs?about 18 years ago
DIABETES WATCHabout 18 years ago
HYPERTENSION WATCHabout 18 years ago
compounding HOTLINEabout 18 years ago
feature: Telepharmacy Improves Safety in Chemotherapy Preparationabout 18 years ago
feature: onePAC Innovates Drug Dispensing on Long-term Careabout 18 years ago
pharmacy TECHNOLOGY productsabout 18 years ago
Stopping Medications Can Cause Adverse EffectsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































